Australia Polymeric Biomaterials Market Size & Outlook
Related Markets
Australia polymeric biomaterials market highlights
- The Australia polymeric biomaterials market generated a revenue of USD 1,603.8 million in 2024 and is expected to reach USD 5,200.0 million by 2030.
- The Australia market is expected to grow at a CAGR of 21.7% from 2025 to 2030.
- In terms of segment, polylactic acid (pla) was the largest revenue generating product in 2024.
- Polytetrafluoroethylene (PTFE) & expanded polytetrafluoroethylene (ePTFE) is the most lucrative product segment registering the fastest growth during the forecast period.
Polymeric biomaterials market data book summary
| Market revenue in 2024 | USD 1,603.8 million |
| Market revenue in 2030 | USD 5,200.0 million |
| Growth rate | 21.7% (CAGR from 2025 to 2030) |
| Largest segment | Polylactic acid (pla) |
| Fastest growing segment | Polytetrafluoroethylene (PTFE) & expanded polytetrafluoroethylene (ePTFE) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polyglycolic Acid (PGA), Polydioxanone (PDO), Polylactic Acid (PLA), Polyurathanes, Polytetrafluoroethylene (PTFE) & expanded polytetrafluoroethylene (ePTFE), Polyaryletheretherketone (PEEK) |
| Key market players worldwide | Stryker Corp, Basf SE, Evonik Industries AG, DSM, Bezwada Biomedical, Corbion NV, Victrex PLC, Covalon Technologies Ltd, Medtronic PLC, Abbott Laboratories, Elixirr International PLC Ordinary Shares, REVA Medical, Meril Life, MicroPort Scientific Corp |
Other key industry trends
- In terms of revenue, Australia accounted for 2.7% of the global polymeric biomaterials market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China polymeric biomaterials market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 11,090.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymeric Biomaterials Market Scope
Polymeric Biomaterials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| REVA Medical | View profile | 51-100 | San Diego, California, United States, North America | https://www.revamedical.com |
| Bezwada Biomedical | View profile | 1-10 | Hillsborough, New Jersey, United States, North America | https://bezwadabiomedical.com |
| Meril Life | View profile | 1001-5000 | Vapi, Daman and Diu, India, Asia | https://www.merillife.com/ |
| Victrex PLC | View profile | 1100 | Victrex Technology Centre, Hillhouse International, Thornton Cleveleys, Lancashire, United Kingdom, FY5 4QD | https://www.victrexplc.com |
| Covalon Technologies Ltd | View profile | - | 1660 Tech Avenue, Unit 5, Mississauga, ON, Canada, L4W 5S7 | https://www.covalon.com |
| Elixirr International PLC Ordinary Shares | View profile | 500 | 100 Cheapside, London, United Kingdom, EC2V 6DT | https://www.elixirr.com |
| MicroPort Scientific Corp | View profile | 8230 | 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 | https://www.microport.com |
| DSM | View profile | 10001+ | Heerlen, Limburg, The Netherlands, Europe | http://www.dsm.com |
| Corbion NV | View profile | 2727 | Piet Heinkade 127, Amsterdam, NH, Netherlands, 1019 GM | https://www.corbion.com |
| Evonik Industries AG | View profile | 33409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | https://www.evonik.com |
| Basf SE | View profile | 111855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | https://www.basf.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Australia polymeric biomaterials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymeric biomaterials market will help companies and investors design strategic landscapes.
Polylactic acid (pla) was the largest segment with a revenue share of 21.59% in 2024. Horizon Databook has segmented the Australia polymeric biomaterials market based on polyglycolic acid (pga), polydioxanone (pdo), polylactic acid (pla), polyurathanes, polytetrafluoroethylene (ptfe) & expanded polytetrafluoroethylene (eptfe), polyaryletheretherketone (peek) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia polymeric biomaterials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia polymeric biomaterials market databook
-
Our clientele includes a mix of polymeric biomaterials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia polymeric biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into Australia polymeric biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia Product - Polymeric Biomaterials Market, 2024 - 2030 (US$M)
Australia Polymeric Biomaterials Market Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
